on 25 Jun 2024
Last Applicant/ Owned by
100 Stierli Court
Mt. Arlington
NJ
07856
Serial Number
98024973 filed on 02th Jun 2023
Registration Number
7426500 registered on 25th Jun 2024
Correspondent Address
Christine Amara
Filing Basis
1. filed as use application
2. use application currently
Disclaimer
NO DATA
Regulatory compliance consulting in the field of life sciences, pharmaceuticals, biotechnology, and medical devices; consulting services to assist life sciences, pharmaceutical, biotechnology and medical device companies in the fields of regulatory compliance, namely, compliance in the areas of aggregate spend disclosure reporting, the Prescription Drug Marketing Act, the Drug Supply Chain Securit Read More
Regulatory compliance consulting in the field of life sciences, pharmaceuticals, biotechnology, and medical devices; consulting services to assist life sciences, pharmaceutical, biotechnology and medical device companies in the fields of regulatory compliance, namely, compliance in the areas of aggregate spend disclosure reporting, the Prescription Drug Marketing Act, the Drug Supply Chain Security Act, Condition of Participation for Outpatient Services, Stark Law and Ohio Terminal Distributor of Dangerous Drugs requirements; compliance audits in the field of life sciences, pharmaceutical, biotechnology and medical device companies regulatory compliance; consulting services in the field of life sciences, pharmaceutical, biotechnology and medical device corporate compliance program and transparency program development, implementation and support; regulatory compliance consulting, namely, reviewing, developing, training on and assisting with the implementation and monitoring of standards, practices, procedures and policies to support regulatory compliance for companies in the fields of life sciences, pharmaceuticals, biotechnology, and medical device
07th Jul 2021
07th Jul 2021
Consulting services in the nature of conducting trainings for life sciences, pharmaceuticals, biotechnology, and medical device companies personnel and partners on pharmaceutical and medical device compliance program requirements, fraud and corruption laws and regulations, industry codes and best practices; consulting services, namely, developing and providing trainings for life sciences, pharmaceutical, biotechnology, and medical device companies in the field of corporate compliance and transparency programs
07th Jul 2021
07th Jul 2021
Business consulting services for life sciences, pharmaceuticals, biotechnology and medical device companies in the nature of regulatory compliance program development and enhancement and transparency program support, namely, reviewing program status and performing gap analyses, drafting programs plans, program implementation support, development and improvement of policies, standard operating procedures and codes of conduct; business consulting services in the nature of monitoring of pharmaceutical and medical device manufacturer interactions with healthcare professionals, healthcare organizations, patients, and other customers; business consulting services in the nature of auditing of pharmaceutical and medical device manufacturer interactions with and payments to healthcare professionals, healthcare organizations, patients, and other customers; business consulting services in the nature of business investigation support for internally and externally raised complaints made against a pharmaceutical or medical device manufacturer related to potential violations of their company policy or code, industry code, or law or regulation; transparency reporting regulatory submission management, namely, assisting others in preparing and filing regulatory submissions in the field of transparency reporting for pharmaceutical, biotechnology and medical device companies; business consulting services, namely, tracking and monitoring regulatory requirements for others in the field of life sciences, pharmaceuticals, biotechnology, and medical devices for regulatory compliance; business consulting services, namely, compliance program gap analysis for life sciences, pharmaceutical, biotechnology, and medical device companies
07th Jul 2021
07th Jul 2021
No 98024973
No Service Mark
No
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
25th Jun 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
25th Jun 2024 | REGISTERED-PRINCIPAL REGISTER |
09th Apr 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
09th Apr 2024 | PUBLISHED FOR OPPOSITION |
20th Mar 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
01st Mar 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
26th Feb 2024 | ASSIGNED TO EXAMINER |
06th Jul 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
06th Jun 2023 | NEW APPLICATION ENTERED |